BMEA

Biomea Fusion, Inc. BMEA

BMEA
Biomea Fusion, Inc. RPTX
Repare Therapeutics Inc. CBUS
Cibus, Inc. IMUX
Immunic, Inc. GUTS
Fractyl Health, Inc. Common Stock UNCY
Unicycive Therapeutics, Inc. CAMP
CAMP4 Therapeutics Corporation ALXO
ALX Oncology Holdings Inc. PMVP
PMV Pharmaceuticals, Inc. ADVM
Adverum Biotechnologies, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BMEA RPTX CBUS IMUX GUTS UNCY CAMP ALXO PMVP ADVM
6M -42.80 % 50.31 % 2.01 % -23.59 % 8.50 % -13.51 % 329.55 % 174.20 % 10.65 % 77.24 %
YTD -63.41 % 67.39 % -48.65 % -39.71 % 4.93 % -25.63 % 34.18 % -9.94 % -21.90 % -9.17 %
1Y -76.92 % 38.09 % -60.93 % -44.59 % 5.92 % -15.86 % 4.01 % -8.77 % -23.40 % -17.11 %
3Y -81.93 % -85.20 % -82.12 % -48.75 % -82.61 % -16.45 % -38.29 % -86.70 % -87.47 % -30.90 %
5Y -92.06 % -94.07 % -99.30 % -96.70 % -82.61 % -88.22 % -38.29 % -98.27 % -97.32 % -96.75 %
10Y -92.06 % -92.83 % -99.73 % -99.85 % -82.61 % -88.22 % -38.29 % -95.32 % -96.81 % -95.07 %
From the beginning -92.06 % -92.83 % -99.73 % -99.87 % -82.61 % -88.22 % -38.29 % -95.32 % -96.81 % -98.44 %

Dividend